Reuters logo
BRIEF-Onconova Therapeutics reports recent business highlights
March 27, 2017 / 1:25 PM / 6 months ago

BRIEF-Onconova Therapeutics reports recent business highlights

March 27 (Reuters) - Onconova Therapeutics Inc

* Onconova Therapeutics, Inc. reports recent business highlights and year-end 2016 financial results

* Onconova Therapeutics Inc - co believes its current cash, cash equivalents will be sufficient to fund ongoing trials and operations into Q4 of 2017

* Onconova Therapeutics Inc - cash and cash equivalents as of December 31, 2016, totaled $21.4 million, compared to $19.8 million as of December 31, 2015

* Onconova Therapeutics Inc - enrollment on track for inspire pivotal trial of IV Rigosertib in 2nd line HR-MDS Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below